AGP Executive Report
Last update: 11 hours agoEU Border Rules: Nine Schengen countries, including Belgium, have told the European Commission they can’t fully enforce the Entry/Exit System (EES) biometric checks yet, after the earlier flexibility expired—aiming to avoid fresh border queues while technical issues are fixed. Belgian Biotech: Antwerp-based Agomab reports positive Phase 1 results for inhaled AGMB-447 in idiopathic pulmonary fibrosis and plans to start its INSPIRIA Phase 2 study before year-end. Food & Ingredients: Puratos (Belgium) says “mouthfeel” is driving new product development as consumers chase crunchier, gooier textures—reshaping chocolate and baked-goods innovation. Healthcare Tech: AGFA HealthCare is showcasing a unified Enterprise Imaging platform at RSNA 2026, targeting less workflow friction for radiology teams. Logistics & Trade: Belgium-linked customs data shows EU low-value parcel volumes falling sharply after the €3 levy, with firms shifting toward bulk imports and storage inside the EU. Industry & Business: Cordiant Digital highlights Belgium among its digital-infrastructure footprint, spanning telecom towers, fibre and data centres.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
